Literature DB >> 15736255

Percutaneous balloon aortic valvuloplasty: antegrade transseptal vs. conventional retrograde transarterial approach.

Yoshihito Sakata1, Zubair Syed, Michael H Salinger, Ted Feldman.   

Abstract

Percutaneous balloon aortic valvuloplasty (BAV) has been limited predominantly to a palliative treatment for poor surgical candidates with critical aortic stenosis and multiple high-risk or comorbid conditions. The most commonly used technique for BAV is the retrograde approach, in which the balloon is passed via the femoral artery using 12-14 Fr sheaths. We compared an antegrade transseptal approach using the Inoue balloon vs. the retrograde transarterial approach using conventional balloons. The antegrade group had an improved acute hemodynamic outcome, including 20% additional increase of aortic valve area and 20% greater reduction of transaortic valve gradient compared to the retrograde approach. Preclosure with the Perclose device was used for the 14 Fr venous access sites, resulting in immediate hemostasis, minimizing the need for transfusion, and diminishing the period of bed rest. The improved acute efficacy and relative ease of venous access for the antegrade approach facilitate BAV by eliminating the need for large-caliber arterial access sheaths. The antegrade approach also incorporates technical elements necessary for percutaneous aortic valve replacement and may have expanded applications as an adjunct to this developing therapy. The impact of improved acute results on the long-term clinical outcome for this patient group will require further study. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15736255     DOI: 10.1002/ccd.20300

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  13 in total

Review 1.  Transcatheter Aortic Valve Replacement: Comprehensive Review and Present Status.

Authors:  Sameer Arora; Jacob A Misenheimer; Radhakrishnan Ramaraj
Journal:  Tex Heart Inst J       Date:  2017-02-01

2.  First clinical experience of the looped Inoue balloon technique for antegrade percutaneous balloon aortic valvuloplasty.

Authors:  Mariko Yano; Naritatsu Saito; Shin Watanabe; Hirotoshi Watanabe; Ryusuke Nishikawa; Takeshi Fujino; Bingyuan Bao; Erika Yamamoto; Hiroki Watanabe; Kenji Nakatsuma; Masao Imai; Takeru Makiyama; Yoshihito Sakata; Takeshi Kimura; Kanji Inoue
Journal:  Heart Vessels       Date:  2014-07-16       Impact factor: 2.037

3.  Real-time transesophageal echocardiography facilitates antegrade balloon aortic valvuloplasty.

Authors:  Yoshihisa Shimada; Kazato Ito; Kentaro Yano; Chiharu Tanaka; Tomohiro Nakashoji; Daisuke Tonomura; Kosuke Takehara; Naoto Kino; Masataka Yoshida; Toshiya Kurotobi; Takao Tsuchida; Hitoshi Fukumoto
Journal:  Cardiovasc Diagn Ther       Date:  2016-04

4.  Optimal surface property for three-dimensional echo visualization.

Authors:  Shunsuke Asakura; Saki Nishikawa; Kazumasa Orihashi; Yoshio Inoue
Journal:  J Med Ultrason (2001)       Date:  2017-10-12       Impact factor: 1.314

5.  Revival of an old method with new techniques: balloon aortic valvuloplasty of the calcified aortic stenosis in the elderly.

Authors:  Stefan Sack; Philipp Kahlert; Sasan Khandanpour; Christoph Naber; Sebastian Philipp; Stefan Möhlenkamp; Burkhard Sievers; Hagen Kälsch; Raimund Erbel
Journal:  Clin Res Cardiol       Date:  2008-04-03       Impact factor: 5.460

6.  Percutaneous balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation: a narrative review.

Authors:  Thomas R Keeble; Arif Khokhar; Mohammed Majid Akhtar; Anthony Mathur; Roshan Weerackody; Simon Kennon
Journal:  Open Heart       Date:  2016-12-07

7.  Antegrade Balloon Aortic Valvuloplasty for the Highly Frail Patient of Severe Aortic Stenosis Complicated with Transthyretin-type Cardiac Amyloidosis.

Authors:  Shohei Yoshida; Hayato Tada; Tetsuo Nishikawa; Tamami Nakagawa-Kamiya; Takuya Nakahashi; Kenji Sakai; Kenji Sakata; Masa-Aki Kawashiri; Masahito Yamada; Masayuki Takamura
Journal:  Intern Med       Date:  2019-12-26       Impact factor: 1.271

8.  Transthoracic delivery of large devices into the left ventricle through the right ventricle and interventricular septum: preclinical feasibility.

Authors:  Majdi Halabi; Kanishka Ratnayaka; Anthony Z Faranesh; Michael S Hansen; Israel M Barbash; Michael A Eckhaus; Joel R Wilson; Marcus Y Chen; Michael C Slack; Ozgur Kocaturk; William H Schenke; Victor J Wright; Robert J Lederman
Journal:  J Cardiovasc Magn Reson       Date:  2013-01-18       Impact factor: 5.364

9.  Numerical model of a valvuloplasty balloon: in vitro validation in a rapid-prototyped phantom.

Authors:  Benedetta Biffi; Giorgia M Bosi; Valentina Lintas; Rod Jones; Spyros Tzamtzis; Gaetano Burriesci; Francesco Migliavacca; Andrew M Taylor; Silvia Schievano; Giovanni Biglino
Journal:  Biomed Eng Online       Date:  2016-04-12       Impact factor: 2.819

10.  Mid-term effect of balloon aortic valvuloplasty on mitral regurgitation in aortic stenosis.

Authors:  Ryota Masaki; Masamichi Iwasaki; Hidekazu Tanaka; Tomoyo Hamana; Susumu Odajima; Wataru Fujimoto; Koji Kuroda; Yutaka Hatani; Takumi Inoue; Hiroshi Okamoto; Masanori Okuda; Takatoshi Hayashi; Ken-Ichi Hirata
Journal:  Cardiovasc Ultrasound       Date:  2020-04-13       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.